Cancer vaccine cuts melanoma risk nearly 50% in breakthrough study
- Posted on June 2, 2026
- By Fox News
- 0 Views
- 1 min read
Cancer vaccine cuts melanoma risk nearly 50% in breakthrough study
A new injectable therapy is showing positive results in reducing melanoma throughout a five-year period. The personalized mRNA cancer therapy, combined with the cancer immunotherapy drug KEYTRUDA, is a collaboration between Merck and Moderna.
